Neuropeptide FF/neuropeptide AF receptors in GtoPdb v.2023.1

The Neuropeptide FF receptor family contains two subtypes, NPFF1 and NPFF2 (provisional nomenclature [12]), which exhibit high affinities for neuropeptide FF (NPFF, O15130) and RFamide related peptides (RFRP: precursor gene symbol NPVF, Q9HCQ7). NPFF1 is broadly distributed in the central nervous system with the highest levels found in the limbic system and the hypothalamus. NPFF2 is present in high density in the superficial layers of the mammalian spinal cord where it is involved in nociception and modulation of opioid functions.

[1]  Peter Buneman,et al.  Why data citation isn't working, and what to do about it , 2020, Database J. Biol. Databases Curation.

[2]  S. Cutler,et al.  Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors , 2014, Journal of medicinal chemistry.

[3]  D. Belsham,et al.  Molecular basis for the activation of gonadotropin-inhibitory hormone gene transcription by corticosterone. , 2014, Endocrinology.

[4]  J. Veldhuis,et al.  Gonadotropin-inhibitory hormone (GnIH) secretion into the ovine hypophyseal portal system. , 2012, Endocrinology.

[5]  K. Tsutsui,et al.  Gonadotropin-inhibitory hormone inhibits GnRH-induced gonadotropin subunit gene transcriptions by inhibiting AC/cAMP/PKA-dependent ERK pathway in LβT2 cells. , 2012, Endocrinology.

[6]  C. Froment,et al.  GRK2 Protein-mediated Transphosphorylation Contributes to Loss of Function of μ-Opioid Receptors Induced by Neuropeptide FF (NPFF2) Receptors* , 2012, The Journal of Biological Chemistry.

[7]  H. Meziane,et al.  Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments , 2012, British journal of pharmacology.

[8]  C. Mollereau,et al.  Anti-opioid effects of neuropeptide FF receptors in the ventral tegmental area , 2011, Neuroscience Letters.

[9]  T. Onaka,et al.  Effects of RFamide‐Related Peptide (RFRP)‐1 and RFRP‐3 on Oxytocin Release and Anxiety‐Related Behaviour in Rats , 2011, Journal of neuroendocrinology.

[10]  L. Moulédous,et al.  Opioid‐modulating properties of the neuropeptide FF system , 2010, BioFactors.

[11]  L. Moulédous,et al.  Modulation of basal and morphine‐induced neuronal activity by a NPFF2 selective agonist measured by c‐Fos mapping of the mouse brain , 2010, Synapse.

[12]  L. Kriegsfeld,et al.  Gonadotropin-inhibitory hormone (GnIH) and its control of central and peripheral reproductive function , 2010, Frontiers in Neuroendocrinology.

[13]  J. Lameh,et al.  Neuropeptide FF Receptors Have Opposing Modulatory Effects on Nociception , 2010, Journal of Pharmacology and Experimental Therapeutics.

[14]  M. Tena-Sempere,et al.  Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications. , 2010, Endocrinology.

[15]  Adam J Pawson,et al.  Identification of Human GnIH Homologs, RFRP-1 and RFRP-3, and the Cognate Receptor, GPR147 in the Human Hypothalamic Pituitary Axis , 2009, PloS one.

[16]  K. Tsutsui,et al.  Gonadotropin‐inhibitory hormone identification, cDNA cloning, and distribution in rhesus macaque brain , 2009, The Journal of comparative neurology.

[17]  Jeremy T. Smith,et al.  Effect of RF-amide-related peptide-3 on luteinizing hormone and follicle-stimulating hormone synthesis and secretion in ovine pituitary gonadotropes. , 2009, Endocrinology.

[18]  E. D. Kirby,et al.  Stress increases putative gonadotropin inhibitory hormone and decreases luteinizing hormone in male rats , 2009, Proceedings of the National Academy of Sciences.

[19]  A. Herbison,et al.  RFamide-related peptide-3, a mammalian gonadotropin-inhibitory hormone ortholog, regulates gonadotropin-releasing hormone neuron firing in the mouse. , 2009, Endocrinology.

[20]  K. Matsumoto,et al.  Bovine C-terminal octapeptide of RFamide-related peptide-3 suppresses luteinizing hormone (LH) secretion from the pituitary as well as pulsatile LH secretion in bovines. , 2009, Domestic animal endocrinology.

[21]  A. N. van den Pol,et al.  Gonadotropin inhibitory hormone inhibits basal forebrain vGluT2‐gonadotropin‐releasing hormone neurons via a direct postsynaptic mechanism , 2009, The Journal of physiology.

[22]  K. Tsutsui,et al.  Hypophysiotropic role of RFamide-related peptide-3 in the inhibition of LH secretion in female rats. , 2008, The Journal of endocrinology.

[23]  Adam J Pawson,et al.  Potent action of RFamide-related peptide-3 on pituitary gonadotropes indicative of a hypophysiotropic role in the negative regulation of gonadotropin secretion. , 2008, Endocrinology.

[24]  J. Bourguignon,et al.  Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[25]  J. Zajac,et al.  Biochemical anti-opioid action of NPFF2 receptors in rat spinal cord , 2007, Neuroscience Research.

[26]  S. Mazères,et al.  Physical Association between Neuropeptide FF and μ-Opioid Receptors as a Possible Molecular Basis for Anti-opioid Activity* , 2007, Journal of Biological Chemistry.

[27]  K. Tsutsui,et al.  Rat RFamide-related peptide-3 stimulates GH secretion, inhibits LH secretion, and has variable effects on sex behavior in the adult male rat , 2007, Hormones and Behavior.

[28]  J. Jhamandas,et al.  Neuropeptide FF (NPFF) control of magnocellular neurosecretory cells of the rat hypothalamic paraventricular nucleus (PVN) , 2006, Peptides.

[29]  C. Mollereau,et al.  Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model , 2006, Peptides.

[30]  M. Iadarola,et al.  Modulatory roles of the NPFF system in pain mechanisms at the spinal level , 2006, Peptides.

[31]  J. Lassalle,et al.  A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice , 2006, Peptides.

[32]  L. Kriegsfeld,et al.  Identification and characterization of a gonadotropin-inhibitory system in the brains of mammals , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. Serre,et al.  Anti-analgesia of a selective NPFF2 agonist depends on opioid activity. , 2005, Biochemical and biophysical research communications.

[34]  Richard R. Neubig,et al.  International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.

[35]  C. Mollereau,et al.  Opioid-modulating peptides: mechanisms of action. , 2005, Current topics in medicinal chemistry.

[36]  C. Mollereau,et al.  Neuropeptide FF (NPFF) Analogs Functionally Antagonize Opioid Activities in NPFF2 Receptor-Transfected SH-SY5Y Neuroblastoma Cells , 2005, Molecular Pharmacology.

[37]  A. Roussin,et al.  Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists. , 2005, European journal of pharmacology.

[38]  J. Jhamandas,et al.  Distribution of the neuropeptide FF1 receptor (hFF1) in the human hypothalamus and surrounding basal forebrain structures: Immunohistochemical study , 2004, The Journal of comparative neurology.

[39]  G. Dockray.  The expanding family of ‐RFamide peptides and their effects on feeding behaviour , 2004, Experimental physiology.

[40]  A. Puget,et al.  Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: A comparative autoradiographic study , 2004, Synapse.

[41]  J. Zajac,et al.  Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones , 2003, Neuroscience Letters.

[42]  S. Hinuma,et al.  Molecular properties of endogenous RFamide-related peptide-3 and its interaction with receptors. , 2003, Biochimica et biophysica acta.

[43]  S. Rice,et al.  Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [125I]EYF as selective radioligands , 2002, Neuroscience.

[44]  N. Elshourbagy,et al.  Neuropeptide AF and FF Modulation of Adipocyte Metabolism , 2002, The Journal of Biological Chemistry.

[45]  M. Parmentier,et al.  Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. , 2002, European journal of pharmacology.

[46]  H. Minakata,et al.  A novel rat hypothalamic RFamide‐related peptide identified by immunoaffinity chromatography and mass spectrometry , 2002, FEBS letters.

[47]  D. Sunter,et al.  Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat , 2001, Neuroscience Letters.

[48]  Jilly F. Evans,et al.  Identification and Characterization of Novel Mammalian Neuropeptide FF-like Peptides That Attenuate Morphine-induced Antinociception* , 2001, The Journal of Biological Chemistry.

[49]  O. Nishimura,et al.  Characteristics and distribution of endogenous RFamide-related peptide-1. , 2001, Biochimica et biophysica acta.

[50]  M. Parmentier,et al.  Agonist and antagonist activities on human NPFF2 receptors of the NPY ligands GR231118 and BIBP3226 , 2001, British journal of pharmacology.

[51]  M. Parmentier,et al.  Functional characterization of a human receptor for neuropeptide FF and related peptides , 2001, British journal of pharmacology.

[52]  C. Mollereau,et al.  [125I]EYF: a new high affinity radioligand to neuropeptide FF receptors , 2001, Peptides.

[53]  J. Zajac.  Neuropeptide FF: new molecular insights. , 2001, Trends in pharmacological sciences.

[54]  B. Borowsky,et al.  Identification and Characterization of Two G Protein-coupled Receptors for Neuropeptide FF* , 2000, The Journal of Biological Chemistry.

[55]  Masaki Tanaka,et al.  New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals , 2000, Nature Cell Biology.

[56]  J. Chambers,et al.  Receptor for the Pain Modulatory Neuropeptides FF and AF Is an Orphan G Protein-coupled Receptor* , 2000, The Journal of Biological Chemistry.

[57]  E. Kalso,et al.  Neuropeptide FF and modulation of pain , 1999, Brain Research.

[58]  J. Zajac,et al.  Neuropeptide FF selectively attenuates the effects of nociceptin on acutely dissociated neurons of the rat dorsal raphe nucleus , 1999, Brain Research.

[59]  M. Hamon,et al.  The neuropeptide FF analogue, 1DME, enhances in vivo met-enkephalin release from the rat spinal cord , 1999, Neuropharmacology.

[60]  E. Kalso,et al.  Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. , 1999, Molecular pharmacology.

[61]  J. Zajac,et al.  Neuropeptide FF, pain and analgesia. , 1998, European journal of pharmacology.

[62]  Adam J Pawson,et al.  Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment. , 1997, Biochemistry.

[63]  J. Zajac,et al.  Hypothermic Effects of Neuropeptide FF Analogues in Mice , 1997, Pharmacology Biochemistry and Behavior.

[64]  Shelagh Wilson,et al.  A human gene encoding morphine modulating peptides related to NPFF and FMRFamide , 1997, FEBS letters.

[65]  H. Arima,et al.  Neuropeptide FF reduces food intake in rats , 1996, Peptides.

[66]  J. Zajac,et al.  Neuropeptide FF reverses the effect of μ‐opioid on Ca2+ channels in rat spinal ganglion neurones , 1996, Neuroreport.

[67]  S. Labrouche,et al.  Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat. , 1995, The Journal of pharmacology and experimental therapeutics.

[68]  L. Stinus,et al.  Neuropeptide FLFQPQRFamide receptors within the ventral mesenchephalon and dopaminergic terminal areas: Localization and functional antiopioid involvement , 1995, Neuroscience.

[69]  K. Jhamandas,et al.  Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. , 1993, European journal of pharmacology.

[70]  B. Roth,et al.  Elevation of arterial pressure in rats by two new vertebrate peptides FLF QPQRF-NH2 and AGE GLSSPFWSLAAPQRF-NH2 which are immunoreactive to FMRF-NH2 antiserum , 1987, Neuropeptides.

[71]  W. Fratta,et al.  Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[72]  L. Kriegsfeld,et al.  Identification, expression, and physiological functions of Siberian hamster gonadotropin-inhibitory hormone. , 2012, Endocrinology.

[73]  H. Vaudry,et al.  Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgammaS binding. , 2007, Neuropharmacology.

[74]  Justin,et al.  RF 9 , a potent and selective neuropeptide FF receptor antagonist , prevents opioid-induced tolerance associated with hyperalgesia , 2006 .

[75]  T. Takeuchi,et al.  Effect of 1DMe, a neuropeptide FF analog, on acetylcholine release from myenteric plexus of guinea pig ileum. , 2001, Japanese journal of pharmacology.